Business Wire

24,000 Registered Attendees Fill the Halls of Successful SPIE Photonics West 2025

Share

The largest annual optics and photonics event of the year highlighted exciting new research, networking, and the latest in photonics products and industry trends

SPIE, the international society for optics and photonics, registered 24,000 optics and photonics professionals from over 75countries for Photonics West, as the Society hosted the largest international annual photonics meeting at San Francisco’s Moscone Center. The dynamic week, which ran from 25 to 30 January, featured 1,588 exhibitors and 5,000 technical presentations across four focused tracks – BiOS, LASE, OPTO, Quantum West – four exhibitions, and the co-located AR | VR | MR conference.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210056991/en/

null

SPIE Photonics West 2025 exhibition opens for business at San Francisco's Moscone Center. (Photo: Business Wire)

“Photonics West marks the start of the optics and photonics calendar every year,” said SPIE CEO Kent Rochford. “And this year, it also marked a truly exciting milestone for SPIE as the Society’s Membership surpassed 25,000! In addition, our newest conference, Quantum West, continues to grow, reflecting the ongoing development of this exciting technological area and its many applications. Throughout the week, Photonics West 2025 proved to be a terrific meeting of minds, showcasing the varied ways optics and photonics technologies are impacting our lives, and now I’m looking forward to Photonics West 2026, an event which is already in the works.”

As always, the action-filled week showcased the latest innovative technologies and discoveries stemming from a diverse and thriving optics and photonics community, bringing together researchers, innovators, engineers, entrepreneurs, and business leaders from across the globe. More than 100 technical conferences complemented the four exhibitions, bringing researchers and companies together to further science, technology, and applications. The week also included a wide range of live product demonstrations on the exhibition floors as well as a job fair.

The SPIE Industry Program continues to highlight key and critical areas. The SPIE Global Business Forum – which brings together top industry executives for high-level presentations, networking, and conversations – was once again a sold-out success. The glamorous Prism Awards, now in its 17th year, celebrated the best new optics and photonics products, while the inspiring Startup Challenge pitch competition recognized three exciting emerging photonics companies. And at the Quantum West Business Summit, speakers and panelists discussed the current trends in this rapidly growing technical and commercial arena.

In addition, 52 educational courses offered expert-led technical training and learning, complementing the many various professional development and networking opportunities on offer throughout the week: From the Lunchtime Professional Development Education series to social events, Photonics West featured a packed calendar of meet-ups, canine-focused relaxation time, and interactive, collaborative gatherings. And in conjunction with Photonics West, SPIE celebrated 20 years of its Women in Optics notebook, bringing together such luminaries as Ursula Keller, Muyinatu "Bisi" Bell, and Jessica Wade for a day-long event of speakers, panelists, and conversations.

While the week held myriad opportunities for attendees to learn, network, and share their latest advancements, it was the buzzing exhibitions – BiOS Expo, the Photonics West exhibition, the Quantum West Expo, and the AR | VR | MR exhibition – that best showcased the increasingly critical photonics industry and the importance of in-person meetings.

“We started out very fast, very busy right off the jump,” said Optikos Director of Operations Dennis Fantone. “It’s been really exciting connecting with old colleagues and friends that hadn’t been to the show before or hadn’t been in a few years. And this is also a great place to meet up not just with customers but with vendors as well: It’s great to get the personal touch that you just get over email and phone.”

“We’ve had really good traffic and have been able to see old customers and suppliers as well as making new contacts,” said Wasatch Photonics Senior Optical Engineer Elroy Pearson. “Photonics West has been really fruitful.”

“I’ve been going to Photonics West ever since it was a tiny, tiny show in San Jose,” said NKT President and CEO Basil Garabet. “We like this show – for us it’s the big show in the US. And because we are very much into the medical and bio area, being at BiOS as well is good for us. We like the position we’re in on the show floor because we don’t have to move – so that works really well for us: we just set up one booth for both shows. Now we are part of Hamamatsu, and they are right across the way, so again that’s worked out really well for us. It’s altogether good, and we look forward to it when we come over. It’s been a very good week.”

“Photonics West 2025 has highlighted the industry’s strong focus on precision, integration, and scalability in optical and photonic technologies,” noted Dr. Efstratios (Stratos) Kehayas, President, Photonics at G&H. “We’ve seen significant interest in advanced laser beam shaping, integrated photonics for compact systems, and high-reliability optical components for demanding applications in industrial, laser fusion and life sciences. The conversations at our booth reflect a growing demand for solutions that enhance performance while addressing challenges in power efficiency, miniaturization, and system integration.”

During the Photonics West week, SPIE also announced its latest SPIE Endowment Matching Program partnerships, one with Boston University and another with National University of Singapore.

As SPIE Director of Sales Jeff Nichols points out, even after this exciting week, there’s so much to look forward to. “The week of Photonics West has always been the best place to see the size and scope of our industry,” notes Nichols. “And in 2026, we're thrilled to be adding VisionTech, a new exhibit and technical program that will showcase the photonics technologies enabling the imaging and vision markets. With the continued growth of Photonics West, SPIE is turning San Francisco in January into a single stop for anyone interested in the latest advancements in photonics technologies and the numerous applications that they enable.”

SPIE Photonics West 2026 will take place 17-22 January at the Moscone Center in San Francisco. The call for papers for the 2026 event will open in Spring of 2025.

About SPIE

SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, we have invested more than $25 million in the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250210056991/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release

‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye